Prognostic Significance of Fatty Liver Disease in Bariatric Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-15

Study Completion Date

2038-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective non-randomized intervention case control study on patients with a BMI \> 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bariatric Surgery on NASH

NCT04043585

Non-Alcoholic Fatty Liver Disease Obesity

COMPLETED

Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery

NCT03391401

Obesity, Morbid Bariatric Surgery Candidate NAFLD +1 more

COMPLETED

Bariatric Endoscopy and NAFLD

NCT04895943

Obesity NAFLD Liver Steatosis +1 more

ACTIVE_NOT_RECRUITING

Bariatric Endoscopy and NAFLD

NCT04669470

Obesity NAFLD Liver Steatosis +1 more

UNKNOWN NA

Bariatric Surgery and Fatty Liver Disease

NCT04569396

Morbid Obesity Diabetes Hypertension

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Alcoholic Fatty Liver Disease Metabolic Encephalopathy Obesity, Morbid Non-alcoholic Steatohepatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

The intervention is bariatric surgery (Roux en Y gastric bypass or gastric sleeve operation).

Group Type EXPERIMENTAL

Bariatric surgery

Intervention Type PROCEDURE

Roux en y gastric bypass or gastric sleeve operation

Control

Age, BMI and co-morbidity matched group who do not undergo surgery.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bariatric surgery

Roux en y gastric bypass or gastric sleeve operation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years
* BMI \>35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark
* Able to give written informed consent.

* Age \> 18 years
* BMI \>35 kg/m2 with no wish to undergo bariatric surgery.
* Able to give written informed consent.